Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations - Test2 - elhamkhani - TriplyDB

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

http://www.wikidata.org/entity/Q28215462

about

sameAs

Genome-wide association studies and the clinic: a focus on breast cancer Li-fraumeni syndrome Polo-like kinase 1 and Chk2 interact and co-localize to centrosomes and the midbody 6-thioguanine selectively kills BRCA2-defective tumors and overcomes PARP inhibitor resistance Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene Multidisciplinary meeting on male breast cancer: summary and research recommendations Genome-wide association study identifies novel breast cancer susceptibility loci Variation of breast cancer risk among BRCA1/2 carriers.A census of human cancer genes Analysis of PALB2/FANCN-associated breast cancer families Ductal approaches to assessment and management of women at high risk for developing breast cancer Frequency of CHEK2 mutations in a population based, case-control study of breast cancer in young women Molecular tumor profiling: translating genomic insights into clinical advances Frequency of CHEK2*1100delC in New York breast cancer cases and controls Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status Familial breast cancer and the hCHK2 1100delC mutation: assessing cancer risk The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer TP53-binding protein variants and breast cancer risk: a case-control study Genetic polymorphisms in DPF3 associated with risk of breast cancer and lymph node metastases.Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer.Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapy Genetic causes of cancer predisposition in children and adolescents Optimal delivery of male breast cancer follow-up care: improving outcomes The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110)NFBD1, a novel nuclear protein with signature motifs of FHA and BRCT, and an internal 41-amino acid repeat sequence, is an early participant in DNA damage response NFBD1/KIAA0170 is a chromatin-associated protein involved in DNA damage signaling pathways Germline mutations in RAD51D confer susceptibility to ovarian cancer The variant E233G of the RAD51D gene could be a low-penetrance allele in high-risk breast cancer families without BRCA1/2 mutations Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations The CHEK2 gene and inherited breast cancer susceptibility EDD mediates DNA damage-induced activation of CHK2 Minding the gap: the underground functions of BRCA1 and BRCA2 at stalled replication forks Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population Cancer evolution and individual susceptibility Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms Deep congenic analysis identifies many strong, context-dependent QTLs, one of which, Slc35b4, regulates obesity and glucose homeostasis

P2860

Q22064616-16A8D5E5-AB36-406B-9230-2495153551A0 Q22241780-524E7099-1E39-4E5C-90DF-E6AFA7E6AB26 Q24337413-ACECAF93-5711-46EA-908F-77C03184681E Q24599364-FD58FA88-4592-4FE9-AC8A-58DB63797654 Q24603375-49A2E3C1-A239-40F4-90DD-9930F337B636 Q24611398-7347D302-6CBA-4EF2-A502-5F0CA47B1881 Q24615080-EC67F8D0-4D74-4284-B2DC-CCA301119C11 Q24631800-272D2F2E-1538-4148-8267-1AA9067AB52A Q24645441-5685615B-969F-40C3-9DDF-6F5653D00E01 Q24646346-A64FE0A0-79B8-41DA-A33C-2FDFE1C0A2A4 Q24647081-795F25DD-4112-4B05-AC04-70E638AF4EAA Q24683771-7AAFE3B6-B5D1-4477-88BD-43602AD04A3B Q24794407-E74CD0EE-8223-487D-91D0-9D1E0F719536 Q24795977-081C4460-59C7-4D07-A30E-EF469DEFD06F Q24797250-186E5752-5113-44F6-A8FC-F4BD2355FEDA Q24798279-B90ABFCA-9EE1-48FF-A795-A4771B247EB1 Q24802534-868816B7-EBD0-49C6-BD18-F5E8FE98E2C6 Q24803409-23964737-949B-452D-BA1B-20EC2D94C4DD Q24806109-09015011-5894-44DE-8BC3-D006D2001170 Q24810703-D7B32A26-60A2-409A-A0EC-6043FD1BA64E Q24814744-9AD3F0B2-AAB7-446D-A03E-DF509EC0087E Q25257392-51970F75-05A7-41A3-B1D3-D2D72A10342A Q26745686-111F78CD-40FD-49F4-B508-A5754E998AE6 Q26770339-0FF2FE9D-D17B-4A94-B5ED-2BBD943AAABC Q26773195-036E9FB0-C580-444A-933E-D480EAAD5E44 Q28074414-C9FF63F5-79DE-4A6D-BF9B-7C8186E6BC67 Q28118922-FB1ADC24-87F1-4B13-BECD-A644CBCAB198 Q28217141-F3FBBA8C-A706-4FDD-9633-77E1BE4DAEEC Q28218966-065F044E-0D19-43B5-896D-90454151CBFB Q28245028-5245F1FE-A539-4638-8882-8425F307DA71 Q28264156-BB535234-2162-46D0-9E28-883190ED6F9F Q28265304-D7A133E2-68C9-4986-B78A-8D74D692916F Q28265315-4245C3A1-FE1F-42CF-A398-F47047FAC52C Q28271191-C3CDFDB8-47D6-43EC-92E5-53B074748F04 Q28294399-11227F0D-6435-4139-ABC4-2CFDA11957A0 Q28388006-12786324-F2E1-46B1-A2D4-88D9C0E418CE Q28389268-0513D66D-3410-46D5-AF3D-F6716870F459 Q28389946-A0103186-7617-422A-B8F3-D72432341996 Q28392728-0C63FBD8-A369-4ACD-8F9D-3528C3E58006 Q28512493-66995BF2-84D9-43C1-A54D-E24816E5DF02

P2860

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

http://www.wikidata.org/entity/Q28215462

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Low-penetrance susceptibility ...... rs of BRCA1 or BRCA2 mutations

@ast

Low-penetrance susceptibility ...... rs of BRCA1 or BRCA2 mutations

@en

Low-penetrance susceptibility ...... rs of BRCA1 or BRCA2 mutations

@nl

type

label

Low-penetrance susceptibility ...... rs of BRCA1 or BRCA2 mutations

@ast

Low-penetrance susceptibility ...... rs of BRCA1 or BRCA2 mutations

@en

Low-penetrance susceptibility ...... rs of BRCA1 or BRCA2 mutations

@nl

prefLabel

Low-penetrance susceptibility ...... rs of BRCA1 or BRCA2 mutations

@ast

Low-penetrance susceptibility ...... rs of BRCA1 or BRCA2 mutations

@en

Low-penetrance susceptibility ...... rs of BRCA1 or BRCA2 mutations

@nl

P1433

Q28215462-2DBE4BFB-98A4-479D-8B55-4192856C8F41

P1476

Q28215462-717242D3-E13F-4D02-9D2E-B323A67A070E

P2093

Q28215462-059213D6-2174-4902-9238-3DF926999433

Q28215462-157E11D1-635F-43DA-AD9F-98FA9CAF1797

Q28215462-18AB59B4-2A22-4B7A-850F-1857838F6451

Q28215462-18D88D38-D3E6-450F-A7A6-3AFB5B07B4E2

Q28215462-1BF399A6-59DE-4AFA-8418-38CEE9B9CEA0

Q28215462-2B4486F5-484A-44DF-9421-CB4CB4BCBF4D

Q28215462-5C512BE3-0807-4CDC-99BD-DCD04A5E22A0

Q28215462-5E34E730-123A-481B-9140-5AFB37B1F08E

Q28215462-6610A0BA-738B-4B8B-BBB8-69793ECA784D

Q28215462-6B58E93D-02B2-4E75-BD98-919948D85DDC

P2888

Q28215462-26357B54-98B3-4185-BFDB-7D1B98032D88

P304

Q28215462-A91EDC6D-372F-48AF-86C8-6FF82A84252A

P31

Q28215462-EC0D9C08-1459-4D48-954F-7B4E10779963

P3181

Q28215462-DC952E11-4248-4932-9BF6-B1B3242D7949

P356

Q28215462-E0119E0A-0207-43AA-B0E0-E250FB4DB970

P407

Q28215462-331F9846-E5AE-442A-8C1D-4C6C660DA5A0

P433

Q28215462-CF2D2B5C-E4C3-44AA-B8E4-7831F0827DDB

P478

Q28215462-43AB18B0-247F-4D22-A27D-28DABEED74BD

P50

Q28215462-0CA69233-FC75-44B8-ABBA-B5AD21FAAF6D

Q28215462-0CE9E2DE-BD7D-4343-BF06-46D46B38C3FD

Q28215462-21268E09-F404-4BBA-BD94-87A9E9583CF4

Q28215462-26B4B854-7E45-4368-ADCA-A9F87AAD57DA

Q28215462-518FE1A4-3CEF-4AAA-BD5B-16875DEFF6C9

Q28215462-5325F997-FC51-4778-BC76-0B0F5095751E

Q28215462-5ADC50F9-5921-4335-9FD1-0006E6A2E4DA

Q28215462-7AAA82AD-90E9-411C-960B-95CE2F11FB48

Q28215462-838E9E51-B126-490C-88BD-963E6739E104

Q28215462-88FB1BBF-EDC4-4089-A8A1-D446173EDDBE

P577

Q28215462-59FFCAE6-D749-45B6-B8F6-C4235D05530E

P5875

Q28215462-C427D0B4-D64A-4A87-9B04-FCAB1D28E064

P698

Q28215462-E637C6B9-8C99-424E-8613-A277FE6E6991

P3181

P356

P1433

Nature Genetics

P1476

Low-penetrance susceptibility ...... rs of BRCA1 or BRCA2 mutations

@en

P2093

Anja de Snoo

http://www.w3.org/2001/XMLSchema#string

Ans van den Ouweland

http://www.w3.org/2001/XMLSchema#string

Barbara Weber

http://www.w3.org/2001/XMLSchema#string

Carel Meijers

http://www.w3.org/2001/XMLSchema#string

Carina Bartels

http://www.w3.org/2001/XMLSchema#string

Catherine Phelan

http://www.w3.org/2001/XMLSchema#string

Csilla Szabo

http://www.w3.org/2001/XMLSchema#string

David Goldgar

http://www.w3.org/2001/XMLSchema#string

Deborah Thompson

http://www.w3.org/2001/XMLSchema#string

Ellen Crepin

http://www.w3.org/2001/XMLSchema#string

P2888

P304

55-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1645969

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NG879

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Jenny Chang-Claude

Cornelia M. van Duijn

Richard Houlston

Antoinette Hollestelle

Hanne Meijers-Heijboer

Katherine L Nathanson

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11399810

http://www.w3.org/2001/XMLSchema#string

P698

11967536

http://www.w3.org/2001/XMLSchema#string